Xeljanz

Xeljanz (tofacitinib) is an oral medication used for managing inflammatory conditions. It belongs to the JAK inhibitor class and is prescribed for adults with moderate to severe rheumatoid arthritis. Always consult a healthcare provider for personalized advice before use.

Xeljanz is primarily used to treat rheumatoid arthritis in adults who have not responded well to other medications. It works by reducing inflammation and slowing joint damage. The medication may also be prescribed for psoriatic arthritis and ulcerative colitis in certain cases. Patients often ask, 'what is Xeljanz used for' to understand its broader applications.

Common effects of Xeljanz include mild nausea, headache, or diarrhea, especially when starting treatment. Some users report fatigue or upper respiratory infections. These effects are generally temporary and may lessen over time as the body adjusts to the medication.

Store Xeljanz at room temperature away from moisture and heat. Keep it out of reach of children and pets. Avoid crushing, breaking, or opening the tablets unless directed by a healthcare professional. Always follow the handling instructions provided with the medication.

Xeljanz may interact with other medications, including certain antibiotics, antifungals, and immunosuppressants. Combining it with live vaccines is not recommended. Alcohol use may increase the risk of side effects, so moderation is advised. Always inform your healthcare provider about all medications you are taking.